Cargando…
The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents
Childhood epilepsy continues to be intractable in more than 25% of patients diagnosed with epilepsy. The introduction of new anti-epileptic drugs (AEDs) provides more options for treatment of children with epilepsy. We review the safety and tolerability of seven new AEDs (levetiracetam, lamotrigine,...
Autores principales: | Kayani, Saima, Sirsi, Deepa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619554/ https://www.ncbi.nlm.nih.gov/pubmed/23650467 http://dx.doi.org/10.4137/JCNSD.S5097 |
Ejemplares similares
-
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review
por: de Jong, Josta, et al.
Publicado: (2016) -
Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational Study
por: Golpayegani, Mehdi, et al.
Publicado: (2019) -
Pharmacokinetic changes for newer antiepileptic drugs and seizure control during pregnancy
por: Yin, Xiaotong, et al.
Publicado: (2022) -
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs)
por: Sommerfeld-Klatta, Karina, et al.
Publicado: (2020) -
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
por: Mahapatra, Manoj K., et al.
Publicado: (2022)